• Set Text Size  
       

Events

MGFA Events Finder & Calendar

MGFA events serve to bring all of us across the MG Community together – whether online or in person. We are proud to offer conferences, seminars, and wellness and research webinars as well as fundraising events such as our MG Walks. We hope you will use this handy MGFA Events Finder List & Calendar to see upcoming or past events, and search for events that mean the most to you.

 

To view upcoming events, scroll down to see the events list or use the calendar on this page and click/tap on colored circle dates. You can also search for an event by typing the event name in the search bar. To view past events, type the name of the event in the search bar or click/tap the left arrow in the calendar. If you have questions, feel free to contact Dova Levin at dlevin@myasthenia.org, or Genna Mvalo at gmvalo@myasthenia.org.

What's New in MG Research: Descartes-08, and RNA CAR T-cell (rCAR-T) therapy for generalized myasthenia gravis and other autoimmune conditions

By Nick Patrone
Event date: 11/29/2022 3:00 PM Export event

What's New in MG Research: Descartes-08, and RNA CAR T-cell (rCAR-T) therapy for generalized myasthenia gravis and other autoimmune conditions

 

Speaker: Miloš Miljković, MD MSc

 

AbstractIn a Phase 2 clinical trial, Descartes-08 — an RNA CAR T-cell (rCAR-T) therapy — appeared to be safe and able to achieve deep and sustained responses in patients with generalized myasthenia gravis. We will discuss results of the trial, and plans for further development of Descartes-08 for myasthenia gravis and other autoimmune diseases.

Register for This Webinar


Speaker Bio: Dr. Miljković is the Chief Medical Officer of Cartesian Therapeutics. He is board-certified in hematology, medical oncology, and internal medicine. Prior to joining Cartesian, he was at the National Cancer Institute for over seven years, where as Staff Clinician he specialized in early-stage trials in immuno-oncology. Dr. Miljković has served as Principal Investigator on 6 clinical trials of immunotherapy and targeted agents and as Associate Investigator on more than 20 others. He completed residency at the Johns Hopkins University and Sinai Hospital of Baltimore program in internal medicine, followed by clinical and research fellowships in the joint NCI/NHLBI program at the NIH, where he also served as Chief Fellow.

 

Share this article

Print

A World Without MG

Donate Now